Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 134532 | 15.305 |
09:34 ET | 6747 | 15.17 |
09:36 ET | 1300 | 15.17 |
09:38 ET | 18277 | 15.22 |
09:39 ET | 926 | 15.23 |
09:41 ET | 4533 | 15.26 |
09:43 ET | 700 | 15.27 |
09:45 ET | 2601 | 15.34 |
09:48 ET | 1058 | 15.35 |
09:50 ET | 1561 | 15.38 |
09:52 ET | 1450 | 15.4122 |
09:54 ET | 2500 | 15.3793 |
09:56 ET | 1929 | 15.42 |
09:57 ET | 3045 | 15.38 |
09:59 ET | 2290 | 15.45 |
10:01 ET | 2570 | 15.46 |
10:03 ET | 1350 | 15.45 |
10:06 ET | 5188 | 15.435 |
10:08 ET | 11971 | 15.3901 |
10:10 ET | 9374 | 15.365 |
10:12 ET | 3691 | 15.305 |
10:14 ET | 4146 | 15.25 |
10:15 ET | 4702 | 15.23 |
10:17 ET | 5380 | 15.21 |
10:19 ET | 2818 | 15.16 |
10:21 ET | 3040 | 15.228 |
10:24 ET | 4516 | 15.28 |
10:26 ET | 2550 | 15.29 |
10:28 ET | 3976 | 15.25 |
10:30 ET | 1572 | 15.235 |
10:32 ET | 1221 | 15.24 |
10:33 ET | 1411 | 15.26 |
10:35 ET | 1390 | 15.26 |
10:37 ET | 3900 | 15.19 |
10:39 ET | 700 | 15.18 |
10:42 ET | 4558 | 15.18 |
10:44 ET | 2569 | 15.19 |
10:46 ET | 11193 | 15.22 |
10:48 ET | 2351 | 15.23 |
10:50 ET | 2200 | 15.195 |
10:51 ET | 3488 | 15.24 |
10:53 ET | 3695 | 15.25 |
10:55 ET | 5687 | 15.235 |
10:57 ET | 10224 | 15.235 |
11:00 ET | 9350 | 15.265 |
11:02 ET | 10001 | 15.23 |
11:04 ET | 800 | 15.23 |
11:06 ET | 4586 | 15.21 |
11:08 ET | 2500 | 15.2 |
11:09 ET | 2564 | 15.18 |
11:11 ET | 200 | 15.19 |
11:13 ET | 10424 | 15.15 |
11:15 ET | 14070 | 15.135 |
11:18 ET | 5495 | 15.095 |
11:20 ET | 2565 | 15.1 |
11:22 ET | 1411 | 15.09 |
11:24 ET | 1099 | 15.1 |
11:26 ET | 1999 | 15.09 |
11:27 ET | 2598 | 15.09 |
11:29 ET | 672 | 15.09 |
11:31 ET | 2563 | 15.12 |
11:33 ET | 1300 | 15.16 |
11:36 ET | 300 | 15.175 |
11:38 ET | 2351 | 15.16 |
11:40 ET | 1082 | 15.17 |
11:42 ET | 1902 | 15.2 |
11:44 ET | 1264 | 15.2 |
11:45 ET | 1200 | 15.2 |
11:47 ET | 930 | 15.18 |
11:49 ET | 400 | 15.18 |
11:51 ET | 1900 | 15.17 |
11:54 ET | 2500 | 15.18 |
11:56 ET | 1507 | 15.17 |
11:58 ET | 1062 | 15.15 |
12:00 ET | 2138 | 15.18 |
12:02 ET | 2129 | 15.18 |
12:03 ET | 1646 | 15.205 |
12:05 ET | 3460 | 15.22 |
12:07 ET | 2304 | 15.19 |
12:09 ET | 2505 | 15.18 |
12:12 ET | 1100 | 15.195 |
12:14 ET | 1390 | 15.21 |
12:16 ET | 1500 | 15.2 |
12:18 ET | 1568 | 15.24 |
12:20 ET | 2446 | 15.225 |
12:21 ET | 600 | 15.23 |
12:23 ET | 1476 | 15.236 |
12:25 ET | 2162 | 15.225 |
12:27 ET | 801 | 15.245 |
12:30 ET | 4309 | 15.255 |
12:32 ET | 1555 | 15.24 |
12:34 ET | 2940 | 15.22 |
12:36 ET | 2939 | 15.28 |
12:38 ET | 3404 | 15.25 |
12:39 ET | 2666 | 15.23 |
12:41 ET | 4040 | 15.22 |
12:43 ET | 1547 | 15.22 |
12:45 ET | 1112 | 15.21 |
12:48 ET | 1300 | 15.215 |
12:50 ET | 9286 | 15.23 |
12:52 ET | 3192 | 15.26 |
12:54 ET | 250 | 15.28 |
12:56 ET | 1056 | 15.32 |
12:57 ET | 6545 | 15.3001 |
12:59 ET | 2452 | 15.29 |
01:01 ET | 412 | 15.29 |
01:03 ET | 1012 | 15.2833 |
01:06 ET | 1556 | 15.28 |
01:08 ET | 1849 | 15.26 |
01:10 ET | 1719 | 15.275 |
01:12 ET | 1225 | 15.27 |
01:14 ET | 2754 | 15.26 |
01:15 ET | 1025 | 15.25 |
01:17 ET | 5555 | 15.265 |
01:19 ET | 1503 | 15.27 |
01:21 ET | 1100 | 15.265 |
01:24 ET | 5540 | 15.24 |
01:26 ET | 6345 | 15.25 |
01:28 ET | 2599 | 15.25 |
01:30 ET | 1916 | 15.25 |
01:32 ET | 2300 | 15.26 |
01:33 ET | 2944 | 15.285 |
01:35 ET | 2327 | 15.28 |
01:37 ET | 1788 | 15.26 |
01:39 ET | 1741 | 15.255 |
01:42 ET | 662 | 15.26 |
01:44 ET | 4103 | 15.27 |
01:46 ET | 1410 | 15.27 |
01:48 ET | 1769 | 15.27 |
01:50 ET | 1712 | 15.28 |
01:51 ET | 612 | 15.28 |
01:53 ET | 1100 | 15.295 |
01:55 ET | 3821 | 15.3 |
01:57 ET | 1740 | 15.315 |
02:00 ET | 4000 | 15.325 |
02:02 ET | 2964 | 15.335 |
02:04 ET | 608 | 15.34 |
02:06 ET | 1201 | 15.33 |
02:08 ET | 1664 | 15.34 |
02:09 ET | 1392 | 15.34 |
02:11 ET | 2317 | 15.345 |
02:13 ET | 3536 | 15.35 |
02:15 ET | 1939 | 15.35 |
02:18 ET | 1600 | 15.34 |
02:20 ET | 2614 | 15.33 |
02:22 ET | 17377 | 15.37 |
02:24 ET | 2157 | 15.38 |
02:26 ET | 4486 | 15.38 |
02:27 ET | 3087 | 15.38 |
02:29 ET | 900 | 15.39 |
02:31 ET | 1260 | 15.38 |
02:33 ET | 4310 | 15.38 |
02:36 ET | 1526 | 15.365 |
02:38 ET | 3591 | 15.35 |
02:40 ET | 2778 | 15.34 |
02:42 ET | 800 | 15.35 |
02:44 ET | 1700 | 15.34 |
02:45 ET | 3322 | 15.375 |
02:47 ET | 4984 | 15.37 |
02:49 ET | 1360 | 15.359 |
02:51 ET | 1433 | 15.355 |
02:54 ET | 2564 | 15.34 |
02:56 ET | 1176 | 15.35 |
02:58 ET | 1435 | 15.37 |
03:00 ET | 2601 | 15.37 |
03:02 ET | 4140 | 15.37 |
03:03 ET | 2149 | 15.38 |
03:05 ET | 1426 | 15.39 |
03:07 ET | 1800 | 15.39 |
03:09 ET | 4613 | 15.4 |
03:12 ET | 2000 | 15.395 |
03:14 ET | 4472 | 15.38 |
03:16 ET | 2534 | 15.375 |
03:18 ET | 2749 | 15.38 |
03:20 ET | 2577 | 15.375 |
03:21 ET | 2081 | 15.355 |
03:23 ET | 2360 | 15.35 |
03:25 ET | 1425 | 15.38 |
03:27 ET | 9506 | 15.37 |
03:30 ET | 890 | 15.37 |
03:32 ET | 3614 | 15.32 |
03:34 ET | 1691 | 15.33 |
03:36 ET | 2931 | 15.33 |
03:38 ET | 3752 | 15.315 |
03:39 ET | 2207 | 15.33 |
03:41 ET | 6264 | 15.335 |
03:43 ET | 3608 | 15.345 |
03:45 ET | 5691 | 15.325 |
03:48 ET | 3270 | 15.335 |
03:50 ET | 5961 | 15.34 |
03:52 ET | 9159 | 15.295 |
03:54 ET | 8403 | 15.295 |
03:56 ET | 15726 | 15.29 |
03:57 ET | 27192 | 15.3 |
03:59 ET | 382822 | 15.3 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.5B | 84.4x | --- |
Azenta Inc | 2.3B | -16.8x | --- |
Guardant Health Inc | 2.7B | -5.4x | --- |
PTC Therapeutics Inc | 2.8B | -5.7x | --- |
Novavax Inc | 2.0B | -4.5x | --- |
Catalyst Pharmaceuticals Inc | 2.4B | 37.9x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.37 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 84.4x |
Price/Sales (TTM) | 2.8 |
Price/Cash Flow (TTM) | 60.4x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.